oncology
Lung

Oncology drug real world outcomes don’t match RCT results


New cancer drugs are less effective in real world settings than the results from the randomised controlled trials used to support their approval, US research shows. A review of outcomes for nine cancer drugs approved since 2008 for 14 indications found that overall survival (OS) rates in 2196 Medicare-eligible patients over the age of 65 ...

Already a member?

Enter your email to keep reading.


OR